Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
14.59
-0.20 (-1.35%)
At close: Sep 4, 2026, 4:00 PM EDT
13.21
-1.38 (-9.46%)
After-hours: Sep 4, 2026, 7:53 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $878.45 million as of September 4, 2026. Its market cap has increased by 271.22% in one year.
Market Cap
878.45M
Enterprise Value
806.51M
1-Year Change
271.22%
Ranking
Category
Stock Price
$14.59
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from $538.37M to $878.45M, an increase of 63.17%. That is a compound annual growth rate of 8.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 878.45M | 205.89% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 940.60M |
| Olema Pharmaceuticals | 938.85M |
| Wave Life Sciences | 926.13M |
| Ardelyx | 924.49M |
| Annexon | 917.56M |
| Rigel Pharmaceuticals | 905.97M |
| Theravance Biopharma | 886.77M |
| Aclaris Therapeutics | 875.83M |